Pharmaceuticals

Plant-Based Vaccines Market Outlook: Growth and Forecast Highlights 2030

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the plant-based vaccines market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Plant-Based Vaccines Market?

The plant-based vaccines market has experienced rapid expansion over recent years. This market is set to increase from $1.81 billion in 2025 to $1.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.2%. The historical growth of this market can be attributed to several factors, including the limited cold chain infrastructure in developing regions, the high cost of conventional vaccine production, the increasing prevalence of zoonotic diseases, early academic research in plant molecular farming, and government support for alternative biologics.

The plant-based vaccines market is anticipated to experience substantial growth in the coming years, with projections indicating it will reach $3.06 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.3%. This expansion is attributed to factors such as an increasing demand for scalable vaccine technologies, the expansion of pandemic preparedness efforts, rising investments in plant biotechnology startups, the need for affordable veterinary vaccines, and favorable regulatory developments for new vaccine platforms. Throughout this forecast period, significant trends are expected to include the broader application of recombinant antigen expression in plants, increased adoption of plant-based platforms for veterinary use, a stronger focus on developing oral and edible vaccines, growing public and private funding for alternative vaccine methods, and advancements in downstream processing and purification technologies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

What Drivers Are Supporting Technological Adoption In The Plant-Based Vaccines Market?

The widespread occurrence of infectious diseases is projected to propel the growth of the plant-based vaccines market in the future. Infectious diseases are illnesses stemming from pathogenic microorganisms, such as bacteria, viruses, or parasites, which can disseminate directly or indirectly, presenting substantial global health risks. The increase in these cases is influenced by factors including greater global mobility, urban overcrowding, and weakened immunity in certain populations. Plant-based vaccines offer innovative platforms that can be rapidly scaled and adapted to address these growing health challenges. For instance, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported that the number of tuberculosis (TB) cases escalated from 8,320 in 2022 to 9,615 in 2023, indicating an increase of 1,295 cases. Thus, the high prevalence of infectious diseases is a key factor driving the expansion of the plant-based vaccines market.

Which Segments Are Contributing To The Growth Of The Plant-Based Vaccines Market?

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

What Trends Are Projected To Support The Growth Of The Plant-Based Vaccines Market?

Key companies in the plant-based vaccines market are forming strategic manufacturing partnerships to broaden their clinical-stage production abilities and hasten the progress of future VLP-based vaccines. These strategic alliances for manufacturing are intended to boost downstream processing efficiency, assure GMP-compliant production, and enable a smooth transition from early-stage research to clinical development. For instance, in December 2024, Aramis Biotechnologies Inc., a Canada-based company focused on plant-based biomanufacturing of novel vaccines, collaborated with Biodextris Inc., a Canada-based CDMO specializing in cGMP complex biologic products, to support Phase 1 and Phase 2 clinical trials. As part of this collaboration, the partner will undertake purification, formulation, and fill-finish processes for plant-expressed VLP vaccine candidates, thereby facilitating quicker scale-up, better production quality, and enhanced preparedness for advanced clinical assessment.

Who Are The Major Companies Operating In The Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market are British American Tobacco PLC, Medicago Inc., Creative Biolabs Inc., Fraunhofer USA Inc., Biodextris Inc., Avesthagen Limited, Calyxt Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG, Zyus Life Sciences Inc., Agenus Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Plant-Based Vaccines Market?

North America was the largest region in the plant-based vaccines market in 2025. The regions covered in the plant-based vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Plant-Based Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

Browse Through More Reports Similar to the Global Plant-Based Vaccines Market 2026, By The Business Research Company

Plant Based Proteins Market 2026

https://www.thebusinessresearchcompany.com/report/plant-based-proteins-market

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Preventive Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795